• 1
    Segre D, Miller RA, Abraham GN, Weigle WO, Warner HR. Aging and the immune system. J Gerontol 1989; 44:1648.
  • 2
    Thoman ML & Weigle WO. The cellular and subcellular bases of immunosenescence. Adv Immunol 1989; 46:22161.
  • 3
    Cossariza A, Ortolani C, Monti D, Franceschi D. Cytometric analysis of immunosenescence. Cytometry 1997; 27:297313.DOI: 10.1002/(sici)1097-0320(19970401)27:4<297::aid-cyto1>;2-a
  • 4
    Solana R & Pawelec G. Molecular and cellular basis of immunosenescence. Mech Ageing Dev 1998; 102:11529.DOI: 10.1016/s0047-6374(98)00029-3
  • 5
    Izaks G, Van Houwelingen H, Schreuder G, Ligthard G. The association between human leucocyte antigens (HLA) and mortality in community residents aged 85 and older. J Am Geriatr Soc 1997; 45:5660.
  • 6
    Ivanova R, Henon N, Lepage V, Charron D, Vicaut E, Schachter F. HLA-DR alleles display sex-dependent effects on survival and discriminate between individual and familial longevity. Hum Mol Genet 1998; 7:18794.DOI: 10.1093/hmg/7.2.187
  • 7
    Neefjes JJ & Momburg F. Cell biology of antigen presentation. Curr Opin Immunol 1993; 5:2734.
  • 8
    Wakikawa A, Utsuyama M, Hirokawa K. Altered expression of various receptors on T cells in young and old mice after mitogenic stimulation: a flow cytometric analysis. Mech Ageing Dev 1997; 94:11322.DOI: 10.1016/s0047-6374(97)01880-0
  • 9
    Sidman CL, Luther EA, Marshall JD, Nguyen KA, Roopenian DC, Worthen SM. Increased expression of major histocompatibility complex antigens on lymphocytes from aged mice. Proc Natl Acad Sci 1987; 84:76248.
  • 10
    Le Morvan C, Cogné M, Troutaud D, Charmes JP, Sauvage P, Drouet M. Modification of HLA expression on peripheral lymphocytes and monocytes during ageing. Mech Ageing Dev 1998; 105:20920.DOI: 10.1016/s0047-6374(98)00096-7
  • 11
    Christinck E, Luscher M, Barber B, William D. Peptide binding to class-I MHC on living cells and quantitation of complexes required for CTL lysis. Nature 1991; 352:6770.
  • 12
    Le Morvan C, Cogné M, Drouet M. An elevation in the concentration of HLA class-I molecules in human blood due to ageing. Mech Ageing Dev 2001; 122:33540.
  • 13
    Van Den Elsen PJ, Gobin SJP, Van Eggermond MCJA, Peijnenburg A. Regulation of MHC class I and II gene transcription: differences and similarities. Immunogenetics 1998; 48:20821.DOI: 10.1007/s002510050425
  • 14
    Soong TW & Hui KM. Locus-specific transcriptional control of HLA genes. J Immunol 1992; 149:200820.
  • 15
    Ligthart GJ, Corberand JX, Fournier C et al. Admission criteria for immuno-gerontological studies in man: the SENIEUR protocol. Mech Ageing Dev 1984; 28:4755.
  • 16
    Vincent R, Louis P, Gongora C, Papa I, Clot J, Eliaou JF. Quantitative analysis of the expression of the HLA-DRB genes at the transcriptional level by competitive polymerase chain reaction. J Immunol 1996; 156:60310.
  • 17
    Arnett KL & Parham P. HLA class I nucleotide sequences. Tissue Antigens 1995; 45:21757.
  • 18
    Schreiber E, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with ‘mini-extracts’ prepared from a small number of cells. Nucl Acids Res 1989; 17:6419.
  • 19
    Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72:24854.DOI: 10.1006/abio.1976.9999
  • 20
    Gobin SPJ, Keijsers V, Woltman AM, Peijnenburg A, Wilson L, Van Den Elsen PJ. Locus specific regulation of HLA class I gene expression. In: CharronD. ed. Genetic diversity of HLA functional and medical implication, vol. II. Paris: Medical and Scientific International Publisher, 1997a: 2957.
  • 21
    Johnson DR. Differential expression of human major histocompatibility class I loci: HLA-A, -B, and -C. Hum Immunol 2000; 61:38996.
  • 22
    Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y. Microdroplet testing for HLA-A, B, C antigens. Am J Clin Pathol 1978; 69:10320.
  • 23
    Le Bouteiller P. HLA class-I chromosomal region, genes, and products: facts and questions. Crit Rev Immunol 1994; 14:89109.
  • 24
    Mansky P, Brown WM, Park JH, Choi JW, Yang SY. The second κB element, κB2, of the HLA-A class I regulatory complex is an essential part of the promoter. J Immunol 1994; 153:508290.
  • 25
    Gobin SJP, Keijsers V, Van Zutphen M, Van Den Elsen PJ. The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor κB. J Immunol 1998; 161:2276–831993.
  • 26
    Girdlestone J, Isamat M, Gewert D, Milstein C. Transcriptional regulation of HLA-A and -B: differential binding of members of the Rel and IRF families of transcription factors. Proc Natl Acad Sci 156872; 90:1.
  • 27
    Cereb N & Yang SY. The regulatory complex of HLA class I promoters exhibits locus-specific conservation with limited allelic variation. J Immunol 1994; 152:387383.
  • 28
    Yao Z, Volgger A, Scholtz S, Albert ED. Sequence polymorphism in the HLA-B promoter region. Immunogenetics 1995; 41:34353.
  • 29
    Park JH, Lee HW, Fleischhauer KL, Kim CG, Scheffery M, Yang SY. DNA-binding proteins for transcription enhancing region of HLA class I gene. Tissue Antigens 1993; 42:7886.
  • 30
    Gobin SJP, Peijnenburg A, Keijsers V, Van Den Elsen PJ. Site α is crucial for two routes of IFNγ-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 1997b; 6:60111.
  • 31
    Girdlestone J. Synergistic induction of HLA class I expression by RelA and CIITA. Blood 2000; 95:38048.
  • 32
    Pawelec G, Effros RB, Caruso C, Remarque E, Barnett Y, Solana R. T-cells and ageing (update February 1999). Front Biosci 1999; 4:21669.